New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Fiber chip thinner than a hair
- Ministry to optimize the structure and scale of university enrollment
- Why do China's cultural and creative products go viral?
- Aviation sci-fi park Nantianmen to open in 2027
- Chinese researchers make breakthrough in green cooling technology
- Former head of national forestry and grassland body under investigation
